Dr. Abdul R. Siddiqui, MD

Dr. Siddiqui practices at Overlake Medical Center in Bellevue, Washington, part of MultiCare Health System.

Dr. Siddiqui's NPI, 1073552709, was assigned on June 6, 2006. Dr. Siddiqui graduated from Dow University of Health Sciences in 1989. Dr. Siddiqui holds Washington license MD60266117.

Dr. Siddiqui's primary practice is Overlake Medical Center, at 1035-116Th Ave NE, Bellevue, WA 98004 in King County. The practice phone is (425) 688-5000.

Dr. Siddiqui's primary practice is Overlake Medical Center in Bellevue, Washington, part of MultiCare Health System. Dr. Siddiqui is also affiliated with EvergreenHealth Medical Center. The medical group on file is Overlake Clinics Cardiology. Dmand AI also links Dr. Siddiqui to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Siddiqui practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Siddiqui's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Siddiqui is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Siddiqui's licenses on file in 3 states: Washington, Ohio and Colorado.

Dmand AI lists acute skin infection, immune deficiency disease, joint or bone infection, pneumonia and UTI among the conditions Dr. Siddiqui treats.

CMS data shows 513 Medicare services from Dr. Siddiqui across 8 procedure codes in 2024, for 177 Medicare patients. Medicare paid $52,685 for them.

CMS counts 177 Medicare patients who saw Dr. Siddiqui in 2024. The largest group is 75 to 84, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Siddiqui's median patient age at 60, with 45% women.

In 2024, Dr. Siddiqui wrote 380 Medicare Part D claims for 105 patients. 89% of them were for generic drugs. CMS names the drug for 224 of them, across 11 drugs with 11 or more claims each, at $34,684 in total drug cost. In 2023, CMS named 282 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Siddiqui for performance year 2024, reported through an alternative payment model (APM). Dr. Siddiqui accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Siddiqui as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Siddiqui.

CMS Open Payments shows 75 general payments to Dr. Siddiqui from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Astellas Pharma US Inc paid the most, $642.

Dmand AI lists 4 awards for Dr. Siddiqui, most recently CMS Stage 1 EHR in 2014.

Dr. Siddiqui graduated from Dow University of Health Sciences in 1989. Dr. Siddiqui is a member of IDSA.

Dr. Siddiqui is in network with 15 carriers, including United Healthcare, Aetna and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.